CD55 Activators

Common CD55 Activators include, but are not limited to Cyclosporin A CAS 59865-13-3, Rapamycin CAS 53123-88-9, Dexamethasone CAS 50-02-2, Retinoic Acid, all trans CAS 302-79-4 and Fluorouracil CAS 51-21-8.

CD55, commonly known as Decay Accelerating Factor (DAF), is a cell surface glycoprotein that plays a pivotal role in the regulation of the complement system, specifically in the complement cascade's alternative and classical pathways. It achieves this regulatory function by accelerating the decay of C3 convertases, thereby preventing the formation of the membrane attack complex (MAC) and protecting host cells from unwarranted complement activation and damage. CD55 is widely expressed across various cell types, including blood cells, endothelial cells, and epithelial cells, signifying its crucial role in ensuring cellular integrity against autologous complement attack.

The chemical class of CD55 Activators encompasses compounds and molecules that enhance the expression, stability, or activity of CD55. These activators may function by promoting the transcription of the CD55 gene, stabilizing its mRNA, enhancing its translation, or directly increasing its activity at the protein level. By amplifying the effects and presence of CD55, these activators contribute to a reinforced protective shield against unintentional complement-mediated cell lysis. In a research setting, CD55 activators can be instrumental in understanding the intricacies of the complement system, its regulatory mechanisms, and the balance between immune surveillance and self-protection. Moreover, by delving into the molecular mechanisms through which these activators operate, scientists can unravel pathways and interactions that underlie the broader immune response framework, fostering a deeper comprehension of immunological processes and homeostasis.